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Abstract
Purpose of Review Burden of occupational disease estimation
contributes to understanding of both magnitude and relative
importance of different occupational hazards and provides
essential information for targeting risk reduction. This review
summarises recent key findings and discusses their impact on
occupational regulation and practice.
Recent Findings New methods have been developed to
estimate burden of occupational disease that take ac-
count of the latency of many chronic diseases and allow
for exposure trends and workforce turnover. Results
from these studies have shown in several countries and
globally that, in spite of improvements in workplace
technology, practices and exposures over the last de-
cades, occupational hazards remain an important cause
of ill health and mortality worldwide.
Summary Major data gaps have been identified particu-
larly regarding exposure information. Reliable data on
employment and disease are also lacking especially in
developing countries. Burden of occupational disease
estimates form an important part of decision-making
processes.
Keywords Occupation . Cancer . Burden estimation .
Respiratory disease . Exposure assessment . Impact
Introduction
Estimation of the burden of disease from different risk factors
is a useful public health tool in assessing premature deaths and
illness. A range of burden measures, such as disease propor-
tions, numbers of deaths, incidence or prevalence of diseases
and quality of life measures, provide decision makers with
data to facilitate prioritisation of risk reduction strategies.
Many studies to date have focused on lifestyle causes of ill-
ness but various environmental and occupational risks are
now increasingly being included.
It is generally accepted that the working environment should
not present a risk of injury or disease but many thousands of
workers worldwide remain exposed to hazardous substances
both in the developed world and particularly in countries that
are rapidly industrialising. Diseases and their risk factors that
rarely if ever occur in non-occupational settings such as silico-
sis and asbestosis continue to be a problem in these countries.
Is occupation important in the global picture of the burden of
disease and is estimating the burden of occupational disease
achievable and worthwhile? This review summarises briefly
the methods commonly used for estimating burden of occupa-
tional disease and gives an overview of some of themore recent
developments. Results from some key studies published in re-
cent years are reviewed. The impact of some of these studies in
raising awareness of occupationally related disease, on regula-
tion and on changing practice in the workplace is highlighted.
The future, or not, of burden estimation is also discussed.
Methods of Estimating Occupational Burden
of Disease
The measure most often used in burden studies is the popula-
tion attributable fraction (PAF) i.e. the proportion of a disease
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that would be avoided in the absence of the risk factor under
consideration. This measure then allows derivation of others
such as numbers of cases, deaths etc. There are a number of
methods that have been used for estimating the PAF. These
include approaches such as:
& The use of the Delphic principle [1] which uses panels of
experts to estimate attributable fraction [2]
& Linkage of national databases such as census and cancer
registry data [3]
& Descriptive studies of incidence or deaths [4]
& Use of absolute risk when the occupational exposure is
considered the only or major cause e.g. asbestos and
mesothelioma[5]
The most common method, however, is to estimate the
PAF by combining a risk estimate for the disease associated
with the agent of concern with the proportion exposed to the
agent in the population of interest using an appropriate equa-
tion [6]. Some form of Levin’s equation [7] is generally used if
the risk estimate is from published studies and the population
exposed is from independent national data; Miettinen’s equa-
tion is appropriate [8] if both data components are from the
same study e.g. a population-based case-control study. Several
studies in different countries have estimated PAFs for occupa-
tionally related cancer using a variety of methods. Burden
estimates range between 3 and 10% partly due to differences
in the numbers of cancers and carcinogens considered [9–16].
The British Study
Current Burden Estimation
The British occupational burden of cancer study developed a
structured approach to evaluating the burden of occupational-
ly related cancer in Britain. The study considered all carcino-
gens and cancer sites classified by the International Agency
for Research on Cancer (IARC) as definite (group 1) or prob-
ably (group 2A) occupational human carcinogens (over 40
carcinogens and 20 cancer sites were included). Cancer laten-
cy was taken into account by defining a risk exposure period
(REP) as the exposure period relevant to a cancer appearing in
the year of burden estimation; 10–50 years was used for solid
tumours and 0–20 years for haematopoietic cancers. The pro-
portion ever exposed at work over the REPwas then estimated
using national data sources, accounting for employment turn-
over and life expectancy, and adjusted for changes in employ-
ment patterns [17]. The risk estimates were obtained from
published literature using expert judgement to select studies
where the patterns of exposure and potential confounders such
as smoking paralleled those of Britain. Disability-adjusted
life-years (DALY), the sum of years of life lost (YLL)
(estimated from cancer deaths and life expectancy) and years
lived with disability (YLD) were also estimated.
Overall, the PAF was about 5% (higher in men, 8% than
women, 2.3%) giving over 8000 attributable cancer deaths
(2005) and approximately 13,500 newly occurring cancers
(cancer registrations) [18]. Figure 1 illustrates the cancer inci-
dence figures for the top 15 carcinogens and the distribution
among the 4 broad occupational groups. The industry of most
concern is construction with 56% of the total attributable can-
cers in men occurring in this industry. For women, 54% of the
total attributable cancers were attributable to shift work (breast
cancer). Unlike the majority of carcinogens associated with
cancers in men which are classified IARC group 1 definite
human carcinogens, shift/night work is currently an IARC
group 2A carcinogen, a probable human carcinogen.
The British team have recently extended their methods to
estimate PAF by age group for the example of melanoma
associated with occupational exposure to solar radiation
[19]. This takes account of variation in cancer rates by age;
the exposed population and national working population have
been assumed to have the same age structure and workers
were assumed to enter the workforce between ages 15–45
and retire at 65. Melanoma was not estimated in the earlier
project because of uncertainty in the relative contributions of
leisure and occupational sun exposure to melanoma risk. The
recent literature is still somewhat equivocal. However, it
seems plausible that work exposure should contribute to the
overall risk. Assuming causality therefore, the estimated PAF
for melanoma associated with sun exposure at work was 2.0%
giving 48 deaths and 241 cancer registrations (newly diag-
nosed melanomas) and an average years of life lost (YLL)
through early death of about 17 years. Once again construc-
tion was the main industry of concern with nearly half of the
deaths and newly diagnosed melanomas followed by agricul-
ture, public administration and defence and land transport.
Over half of the melanomas occurred after retirement age
(65+), highlighting the fact that the long latency of occupa-
tional cancers may lead to the cancer occurring many years
after leaving work.
Extension to Economic Costs
These burden estimates and in particular the quality of life
results have been used by economists from the Health and
Safety Executive (HSE) to quantify the economic cost of ex-
posures to workplace carcinogens in Britain [20•]. Total eco-
nomic costs to society of new cases of work-related cancer in
Britain in 2010, arising from past working conditions, are
estimated as approximately £12.3 billion with the three major
cancers being lung (£6.8 billion), mesothelioma (£3.0 billion)
and breast (£1.1 billion). Individuals bear almost all (£12.0
billion, 98%) of the costs of work-related cancer due largely
to ‘human’ costs—a monetary value on the effects of cancer
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on quality of life or loss of life for fatal cancers (£11.4 billion).
By comparison, only £461million is borne by employers. The
authors point out that the work-related cancers often occur
after retirement due to the long latency between occupational
exposure to carcinogens and development of many cancers.
Thus, employers do not incur costs such as disruption from
sickness absence and paying sick pay.
Predicting Future Burden
Estimation of the current burden for different occupational
carcinogens provides valuable data for decision makers.
However, prediction of the potential effectiveness of reduction
programmes is also desirable. To this end, the British team
extended their methodology to forecast the burden associated
with the carcinogens shown in Fig. 1 at several time points in
the future for a range of scenarios, such as the introduction of
new occupational exposure limits, increased levels of compli-
ance with these limits and other reductions in worker expo-
sure. Risk exposure periods were projected forward in time
with the contribution of past exposure to future cancer risk
decreasing as time points increased. Adjustments were made
for predicted employment turnover and life expectancy, and
adjusted for changes in employment patterns as in the current
burden methods [21]. Without intervention, occupational at-
tributable cancers were forecast to remain at over 10,000 an-
nually by 2060 [22]. Effective interventions were shown to be
reduction of workplace exposure limits and in particular im-
proving compliance with these limits.
Global Burden of Occupational Disease
Although estimation of occupationally related mortality and
morbidity in single countries may be achievable, attempts to
do this globally have faced enormous challenges of data avail-
ability, quality and collation. Not least is the issue of exactly
what constitutes an occupational risk and which of these and
their associated diseases is it feasible to include. Estimates of
the global burden of occupational disease thus vary although a
general conclusion is that the problem is a major one and
probably most estimates are under-estimates.
The International Labour Organisation and the World
Health Organisation have both been key players in the effort
to enumerate this issue; both organisations update their esti-
mates at regular intervals. They arrive at similar estimates of
5–7% of global fatalities attributable to work-related illnesses
and occupational injuries [23, 24]. Takala et al. 2012 provide
an overview of data on employment and occupational mortal-
ity and morbidity, publically available literature and reports on
occupational burden of disease [25]. They estimate that glob-
ally there are 2.3 million occupationally related deaths each
year attributable to work with the majority, 2.0 million, being
due to occupational diseases. Overall, cancer forms the largest
Fig. 1 Numbers of
occupationally related cancer
registrations (2011) by carcinogen
and major industry sector
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component (32%) followed by work-related circulatory dis-
eases (23%), communicable diseases (17%) and occupational
accidents (18%) with the latter two being far more prevalent in
developing and rapidly industrialising countries. For cancer,
this translates to 660,000 deaths with asbestos being the
exposure contributing the largest proportion [26].
Another International Labour Organisation publication
gives information on non-fatal occupational accidents
and fatal occupational cancers. Over 313 million non-
fatal occupational accidents (with at least 4 days ab-
sence) in 2010 are estimated, and over 666,000 fatal
occupationally related cancers [27].
The WHO has conducted Comparative Risk Assessments
(CRA) to estimate burden of disease as part of the Global
Burden of Disease project; this provides comprehensive de-
scriptive data, including trends, in mortality and morbidity
from major diseases, injuries and risk factors. Several esti-
mates have been published since 1990 [28] and 2010 [29],
with the 2010 GBD study updated in 2013 [30] and 2015
[31]. To attempt to ensure consistency worldwide, the GBD
project has stringent data requirements and this has thus lim-
ited the risk factors evaluated and in particular for occupation
which has been included since 2000. The first occupational
estimates included only lung cancer (8 lung carcinogens), me-
sothelioma and leukaemia (3 leukemogens) and estimated
globally that there were 152,000 deaths annually from occu-
pational cancers (lung cancer 102,000, leukaemia 7000, me-
sothelioma 43,000) and nearly 1.6 million DALYs mainly
originating from lung cancer and mesothelioma [32]. The
most recent update (2015) incorporated and extended the
methods used by the British occupational cancer burden study
and included 14 carcinogens (IARC group 1) (compared with
30 group 1 carcinogens and 10 group 2A carcinogens in the
British study) related to seven cancer types—kidney (trichlo-
roethylene), lung (arsenic, asbestos, beryllium, cadmium,
chromium VI, diesel engine exhaust, second-hand smoke
(from tobacco smoking) (SHS), nickel, polycyclic aromatic
hydrocarbons (PAHs), silica), larynx (asbestos, strong
inorganic-acid mists), leukaemia (benzene, formaldehyde),
mesothelioma (asbestos), nasopharynx (formaldehyde) and
ovary (asbestos). In addition, occupational burden was esti-
mated for asthmagens, particulate matter, gases and fumes
(PMGF), noise, ergonomic risk factors for low back pain,
and risk factors for occupational injury [33]. 1,086,000 deaths
were estimated to occur globally due to occupational risks.
These include 489,000 occupationally related cancer deaths
with important causes being asbestos (180,000), diesel engine
exhaust (120,000), silica (86,000) and SHS at work (96,000);
SHS has largely been banned in the workplace in many de-
veloped countries but still remains a major issue in developing
and rapidly industrialising countries. Occupational exposure
to asthmagens is estimated to cause 42,000 deaths, with
PMGF causing 357,000 (mainly COPD) and workplace
injuries causing 204,000 deaths. Figure 2a shows the distribu-
tion of deaths by cause across the 21 WHO regions [34•].
Occupational risks are ranked eleventh in terms of total
DALYs for men and thirteenth for women, with dietary risk
ranked top for both, followed by smoking for men and child
and maternal malnutrition for women and high systolic blood
pressure for both. Total occupational DALYs are 63,600 approx-
imately with low back pain contributing 18,400 followed by
occupational injuries 13,500, noise 10,900 and occupational car-
cinogens 9800. These DALY results highlight the huge burden
worldwide caused by occupationally-related morbidity. In many
countries the leading cause of sickness absence is musculoskel-
etal disorders. Figure 2b shows the DALYs by WHO region.
Ongoing Work Around the World
Canada
The Canadian study ‘the human and economic burden of can-
cer in Canada’ is a collaborative study of Canadian re-
searchers. The study has extended and expanded the methods
developed by the British team to use much more detailed
exposure data about Canadian workplace exposure to carcin-
ogens including number exposed and also exposure measure-
ments. A major component is the use of the burden of occu-
pational cancer estimates in combination with information on
costs of health care and administration, informal caregiving,
output and productivity losses and health-related quality life
losses to estimate the economic burden of newly diagnosed
occupational cancers. This includes all current and future costs
incurred by afflicted workers, their families, communities,
employers and society at large. Throughout the study period,
the research team has actively engaged with funders and
stakeholders [35]. Preliminary results have been discussed
and final results are expected in the near future.
USA
The USA is included as one of the WHO regions analysed in
the GBD study. However, there is no comprehensive study of
the current occupational disease burden due to past exposures
for the USA. Purdue et al. [36] reviewed published estimates
of occupational cancer burden but identified only 2 for the
USA that estimated current burden, the Doll and Peto study
of 1981 (4%) [9] and a later paper by Steenland et al. [11]
(2.4–4.8%) [11]. For the examples of bladder and lung cancers
due to work as a painter and shift (night) work associated with
female breast cancer, Purdue et al. used the methods from the
British study to demonstrate the potential usefulness of burden
estimation for informing prevention. Work as a painter
accounted for a very small proportion of cancers of the bladder
and lung in 2010, with PAFs of 0.5% for each site. The results
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for shift work contrasted with this giving a PAF of 5.7%,
translating to 11,777 attributable breast cancers.
Australia
An estimate of the burden of occupational cancer in Australia
by Fritschi and Driscoll [37] applied Finnish estimates of the
proportion of cancers caused by occupation to numbers of
cancers in Australia and applied European Union estimates of
the proportion of workers exposed to carcinogens to Australian
industrial data [37]. They estimated that about 5000 incident
cancers each year were due to occupation (11% males, 2%
females) with about 34,000 occupationally related
non-melanoma skin cancers. In addition, they estimated that
Fig. 2 a Numbers of global occupationally related deaths in 2015 by
WHO region and major disease group (This figure was derived from
data available on the following site: GBD Compare. IHME, University
of Washington; 2016. https://vizhub.healthdata.org/gbd-compare/.
Accessed January 2017.). b Numbers of global occupationally related
DALYS in 2015 by WHO region and major disease group. (This figure
was derived from data available on the following site: GBD Compare.
IHME, University of Washington; 2016. https://vizhub.healthdata.org/
gbd-compare/. Accessed January 2017)
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there were about 1.7 million workers in Australia occupation-
ally exposed to carcinogens.
To provide more objective figures on the numbers of
Australians exposed to workplace carcinogens, the
Australian Work Exposures Study (AWES) surveyed a ran-
dom sample of just over 5000 currently employed men and
women and interviewed them by telephone about their current
job [38]. A web-based application (OccIDEAS) [39] was
utilised in which participants were asked about their job tasks
and predefined algorithms were then used to automatically
assign exposures. 37.6% were assessed as being exposed to
at least one occupational carcinogen in their current job sug-
gesting that 3.6 million (40.3%) current Australian workers
could be exposed to carcinogens in their workplace.
Exposure prevalence was highest among farmers, drivers,
miners and transport workers.
The Australian team then developed a lifetime risk ap-
proach to predict how many workers exposed now would
develop a future cancer. This addresses burden from a differ-
ent perspective than the more commonly used PAF approach
which estimates the burden now from exposure in the past.
The lifetime risk approach is useful if information on past
exposure is scarce; however, it requires prediction of future
general population disease risk which is a potential source of
inaccuracy. The ‘future excess model’ developed by Fritschi
et al. [39] estimates the lifetime excess fraction due to a work-
place carcinogen exposure and is based on disease-free popu-
lation’s person-years rather than the total population, takes
account of age-specific survival and uses a risk estimate ob-
tained from the literature for each carcinogen and its associat-
ed cancer site. It should be noted that the future excess fraction
is not directly comparable with the PAF [40].
It was estimated that out of the Australian working popu-
lation who were exposed to occupational carcinogens in 2012,
the number of occupationally related cancers that would de-
velop over the period to 2094 would be 68,500 (1.4%), with
the majority being lung cancers (26,000), leukaemias (8000)
and malignant mesotheliomas (7500) [41].
Impact of the Occupational Burden Studies
Burden estimation studies have the potential to influence pol-
icies that effect improvement in health of workers. The HSE
have used the information from the British cancer burden
study to inform the development of their health strategies, in
their guidance documents and to identify practical interven-
tions together with stakeholders. The results have been simi-
larly used to make workers aware of the issue of occupational
disease and cancer by worker organisations such as the Trade
Union Council and have underpinned a major campaign, the
‘No time to lose’ launched by the Institution for Occupational
Safety and Health (IOSH) [42]. The campaign provides free
practical, original materials to businesses to help them deliver
effective prevention programmes and encourages them to sign
up to committing to reduce exposure to carcinogens.
There is increasing interest in evaluating the financial im-
pact of work-related disease and cancer in particular on both
workers and industry and incorporating this into decision-
making. The European Union (EU) have used results from a
socio-economic health and environmental impact assessment
of introducing binding occupational exposure limits (OEL) for
25 work place carcinogens to inform, together with other data,
changes to EU legislation. Methods from the British cancer
burden study were extended to estimate health costs and ben-
efits of introduction of up to three different OELs compared to
no intervention [43]. Compliance costs were separately esti-
mated and a cost-benefit ratio was calculated. The cost-benefit
results have made a strong impact on the decision-making
process although for a few carcinogens the proposed OEL is
greater than that based on a health-based risk assessment ar-
rived at by one of the EU Scientific Committees [44]. Greater
health benefits gained from lower values can be outweighed in
the decision-making process if there is thought to be a ‘dis-
proportionate’ cost to certain sectors of industry, for example,
small and medium-sized enterprises, even if these are the very
ones where higher exposures are expected to be found.
Discussion and Conclusions
This paper has provided an overview of the findings from
some of the projects estimating the burden of disease from
exposure to workplace hazards. There is a burgeoning re-
search industry in this area and several ongoing studies will
be reporting their results in the next few years. These include
the Canadian study described earlier, more detailed results on
occupation from the Global Burden of Disease 2015, a study
in the Singapore construction industry, a large project in
France estimating the burden of disease from many risk fac-
tors including occupation led by IARC and an EU OSHA
study to evaluate the economic burden of exposure to occu-
pational carcinogens in the EU. Many of them have extended
and improved existing methodology to address data inadequa-
cies and assumptions and also important country-specific cir-
cumstances, for example if a large proportion of the workforce
is non-resident and/or transient.
Data limitations and assumptions made lead to uncer-
tainties about the ‘true’ magnitude of the results. Random
error confidence intervals go some way to expressing the un-
certainty but do not address potential uncertainty sources such
as: assumptions about cancer latency and thus the length of the
relevant exposure window before cancer development; lack of
data on the proportions exposed at different exposure levels
within industry sectors or jobs; choice of the risk estimates and
whether the studies from which these are chosen are
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compatible with the population of concern regarding expo-
sures, confounders etc.; use of risk estimates from studies of
occupational groups affected by the healthy worker effect i.e.
a reduced overall risk estimate compared to the general pop-
ulation leading to an underestimation of the true effect and
thus an underestimation of the burden; methodological
issues such as the use of Levin’s equation with adjusted
risk estimates and employment turnover methodology.
Credibility intervals exploring the relative contributions
of important sources of uncertainty have shown that the
choice of relative risk and the employment turnover
estimates contribute most to overall estimate uncertainty
with bias from using an incorrect estimator making a
much lower contribution [45].
The magnitude of the overall burden depends on which
diseases and risk factors and how many are included. An
update of an overall cancer burden estimate to include addi-
tional carcinogens, for example as a result of further agents
being classified as definite human carcinogens by IARC, will
generally give a higher overall AF and the relative importance
of each agent included previously will potentially change.
Changes in the relative importance may also occur when an
intervention is introduced and an individual risk has been
reduced. In a non-occupational setting, the incidence of sud-
den infant death syndrome (SIDS) greatly reduced after a
campaign to encourage parents to lay their babies on their
sides or back. However, the relative importance of smoking
and bottle feeding then became more apparent [46]. Thus,
caution is required when interpreting the absolute numbers
from burden of disease studies although these can serve to
emphasise the importance of a particular risk factor or effect
on a certain disease group. Of particular use, however, is the
use of ranked relative measures by disease, exposure, industry
etc.
How much more burden estimation should we do and how
often should we repeat the exercise? Compared with occupa-
tional cancer burden studies, there are far fewer focusing on
cardiovascular disease (CVD). Estimates from 6 previous
studies range from 1 to 23% but cover different outcomes
e.g. CVD overall, ischaemic heart disease, acute myocardial
infarction, hypertension etc. and different combinations of po-
tential exposures e.g. noise, low job control, shiftwork, SHS,
psychosocial stress etc. [11, 12, 47–50]. There is, however, a
substantial literature on work-related factors that might in-
crease risk of various CVD outcomes. In addition to the
above, exposures investigated include sedentary work, noise,
heat, irradiation and a number of chemicals including lead,
cobalt, arsenic, carbon monoxide, solvents etc. Like many
cancers, there are also well-established personal characteris-
tics and lifestyles that contribute to increased CVD risk which
need taking into account. However, unlike cancer, there is no
well-respected and established system of classification of oc-
cupational hazards for CVD. Estimation of occupationally
related CVD thus presents methodological and data chal-
lenges which would benefit from future research.
The GBD project has a programme of regularly
updating and revising their estimates, sometimes every
1 or 2 years. This may cause confusion among potential
users especially if numbers are very different without
obvious reasons e.g. if methods have been revised. If
the status quo remains the same then perhaps resources
might be better used in filling some of the gaps identi-
fied in these studies. Individual countries wishing to
carry out their own burden estimation may also find
that they can fairly easily adapt either existing methods
and/or existing data such as risk estimates or even
PAFs.
Major data gaps exist particularly regarding lack of
exposure measurement data and inadequate national in-
formation on employment, numbers of exposed individ-
uals and the levels to which they are exposed. In addi-
tion, in many countries, occupation is not a mandatory
item in routinely collected health data such as family
doctor and hospital records and cancer registrations. A
global effort to fill this gap would facilitate evaluation
of occupational risks and allow use of techniques such
as application of job exposure matrices.
The use of burden of occupational disease estimates by the
EU to set occupational exposure limits has highlighted the fact
that decision makers will use these figures together with other
major information on costs, benefits, numbers exposed, coun-
tries and size of industries involved, and toxicological risk
assessments. The opinion of members of one or more expert
committees will also influence final decisions. Further devel-
opment of methods to predict how future burden can be im-
pacted by different interventions and validation of these with
data for example from exposure monitoring would be
valuable.
In conclusion, burden estimation is an important public
health tool to inform risk reduction strategies and the preven-
tion of disease caused by workplace exposures.
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